GGrantIndex
← Search

IMMUNOMODULATION BY IMIQUIMOD IN PRIMARY MELANOMA

$2,923M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →